Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 8cyclopia sequence 6Prostatic Neoplasms 3Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Urinary Bladder Neoplasms 2Polycystic Ovary Syndrome 2Pancreatic Neoplasms 2Neoplasms, Plasma Cell 2Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 2Hematologic Diseases 2Head and Neck Neoplasms 2Fatigue 2Warts 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Recurrence 1Prostatic Intraepithelial Neoplasia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Papilloma 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Neuromyelitis Optica 1Myelitis, Transverse 1Myelitis 1Melanoma 1

Interventions

Lycopene 3padeliporfin 2Vitamin E 2Tea 2Selenium 2Cholecalciferol 2relatlimab 1pembrolizumab 1Therapeutics 1Sugars 1Nivolumab 1CP protocol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Male Urogenital Diseases × Sugars × Clear all
NCT01443026 2019-11-19

The Effects of Lycopene on High Risk Prostatic Tissue

University of Illinois at Chicago

Phase 2 Completed
66 enrolled 8 charts
Genitourinary

Prostatic Neoplasms, Prostatic Intraepithelial Neoplasia, Male Urogenital Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡